An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)
| Autor: | Chen, Christine I., Snitzler, Susi *, Wang, Trina *, Paul, Harminder *, Le, Lisa W *, Wei, Ellen Nong *, Lau, Anthea *, Smith, Deborah A *, Brown, Michelle *, Johnston, James B, Trudel, Suzanne |
|---|---|
| Zdroj: | In Blood 15 November 2013 122(21):4175-4175 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|